Senior insider sale
President and Chairman at Y-MABS THERAPEUTICS, INC. — senior position signals high conviction
$1.37M
100K shares
What this filing means
GAD THOMAS plans to sell 100K shares of Y-MABS THERAPEUTICS, INC. valued at approximately $1.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/13/2024ACC: 0001968582-24-000828
DirectorOfficer· President and Chairman
Since Sep 2018
100K
Shares to sell
$1.37M
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Investment
Cash
8/15/2015
100KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/15/2015 | Private Investment Cash | 100K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
100K
Market value
$1.37M
9/13/2024
Total
Units
100K
Value
$1.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/13/2024 | 100K | $1.37M | Nasdaq | Planned |
| Total | 100K | $1.37M | ||